In this episode of NGBiLab, host Jim Wilson welcomes the innovative minds behind YellowBird Diagnostics: Nicholas Calvert, Alexia Kirby, and Adam Shuhendler. Discover how this dynamic team, spun out of the University of Ottawa, is revolutionizing disease diagnosis with cutting-edge chemical technologies. From their entrepreneurial journey to the challenges of bringing molecular imaging to the clinic, this conversation delves into the heart of innovation in the life sciences sector. Tune in to learn about their vision to become leaders in advanced imaging dye innovation and their plans for the future.

In this archived episode of NGBiLab, host Jim Wilson revisits his conversation with Bronwyn Bridges, CEO and co-founder of PragmaClin, a pioneering startup from St. John's, Newfoundland. PragmaClin's innovative digital tool, Prims, is designed to enhance the assessment of Parkinson's disease, offering more objective and efficient pathways for neurological care. Bronwyn reflects on her journey, the hurdles overcome, and the serendipitous moments that shaped PragmaClin's mission to make healthcare more accessible.

In this throwback episode of NGBiLab, host Jim Wilson sits down with Kevin Neal and Jean-Francois Mio from Tatum Bioscience in Sherbrooke, Quebec. Discover how they are revolutionizing cancer treatment by programming bacteria to become cancer-fighting drugs. Learn about their journey, the challenges they face, and their vision for the future of immunotherapy. Tune in to explore the cutting-edge innovations in Canada's life sciences sector.

This week, we’re throwing it back to when Jim connected with Sydney Robinson, CEO and co-founder of Vessl Prosthetics, based in London, Ontario. Sydney and her team are pioneering next-generation prosthetic solutions specifically designed for below-knee amputees. Their innovative technology features automatic adjustments that ensure a consistently comfortable fit—greatly improving quality of life for many.

In 2025, Vessl Prosthetics made significant strides, securing key funding and expanding their impact in the prosthetics field. Their journey perfectly exemplifies the spirit of innovation and collaboration that NGBi is proud to amplify—showcasing real-world breakthroughs happening across Canada’s life sciences ecosystem.

Tune in to hear their inspiring story, and stay connected for more fresh conversations coming soon!

In this special edition, we revisit the inspiring journey of Serena Mandla and Carla Spina, co-founders of NOA Therapeutics. Learn how these innovators are transforming the treatment of complex inflammatory diseases with their multimodal therapeutics. From their serendipitous meeting to overcoming challenges as female founders, Serena and Carla share their passion for innovation, collaboration, and making a meaningful impact in the life sciences community.

This archived episode is a perfect preview of the visionary leaders and groundbreaking ideas you’ll encounter at the NGBi2025 Summit. Dive in for an insightful conversation about the future of healthcare and the people shaping it.

Join us as we dive into the world of medical innovation with Dr. Rob Arntfield, founder of Deep Breathe. Discover how AI is revolutionizing portable ultrasound technology, making diagnostics more accessible in both military and healthcare settings. Dr. Arntfield shares insights from his journey as an ICU physician and entrepreneur, highlighting the challenges and triumphs of bringing cutting-edge technology to life. Tune in to explore the future of medical diagnostics and the impact of AI on healthcare. #MedicalInnovation #AI #Healthcare

In this episode, we delve into the complex world of diagnosing endometriosis with Lauren Foster, Professor Emeritus at McMaster University and co-founder of Afynia Labs. Discover the challenges faced by women in obtaining a diagnosis, often taking 10-12 years and multiple doctor visits. Lauren shares insights into the innovative microRNA-based blood test developed by Afynia Labs, aiming to provide a quicker, non-invasive diagnostic solution. Join us as we explore the journey of bringing this groundbreaking test to market and its potential to transform women's healthcare.

In this episode, we delve into the groundbreaking work of Dr. Jeffrey Coull and his team at Grey Matter Neurosciences. Discover how their pioneering ultrasound technology aims to enhance cognitive function in patients with Alzheimer's and other cognitive impairments. Join us as we explore the potential of this revolutionary approach to brain stimulation, offering hope for improved memory, attention, and language fluency. Tune in to learn about the future of cognitive enhancement and the exciting developments in neurotechnology. Plus, don't miss Dr. Coull at NGBi25, happening Tuesday, October 21st, in Hamilton, Ontario.